Charles River Laboratories International, Inc. (CRL)
NYSE: CRL · Real-Time Price · USD
187.90
+1.80 (0.97%)
Nov 20, 2024, 4:00 PM EST - Market open
CRL Employees
Charles River Laboratories International had 21,800 employees as of December 31, 2023. The number of employees increased by 400 or 1.87% compared to the previous year.
Employees
21,800
Change (1Y)
400
Growth (1Y)
1.87%
Revenue / Employee
$186,281
Profits / Employee
$18,949
Market Cap
9.61B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 21,800 | 400 | 1.87% |
Dec 31, 2022 | 21,400 | 1,400 | 7.00% |
Dec 25, 2021 | 20,000 | 1,600 | 8.70% |
Dec 26, 2020 | 18,400 | 1,300 | 7.60% |
Dec 28, 2019 | 17,100 | 2,400 | 16.33% |
Dec 29, 2018 | 14,700 | 2,900 | 24.58% |
Dec 30, 2017 | 11,800 | 800 | 7.27% |
Dec 31, 2016 | 11,000 | 2,400 | 27.91% |
Dec 26, 2015 | 8,600 | 700 | 8.86% |
Dec 27, 2014 | 7,900 | 200 | 2.60% |
Dec 28, 2013 | 7,700 | 500 | 6.94% |
Dec 29, 2012 | 7,200 | 100 | 1.41% |
Dec 31, 2011 | 7,100 | -400 | -5.33% |
Dec 25, 2010 | 7,500 | -500 | -6.25% |
Dec 26, 2009 | 8,000 | -1,000 | -11.11% |
Dec 27, 2008 | 9,000 | 500 | 5.88% |
Dec 29, 2007 | 8,500 | 500 | 6.25% |
Dec 30, 2006 | 8,000 | -400 | -4.76% |
Dec 31, 2005 | 8,400 | 400 | 5.00% |
Dec 25, 2004 | 8,000 | 3,500 | 77.78% |
Dec 27, 2003 | 4,500 | -500 | -10.00% |
Dec 28, 2002 | 5,000 | 1,000 | 25.00% |
Dec 29, 2001 | 4,000 | 500 | 14.29% |
Dec 30, 2000 | 3,500 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Encompass Health | 37,761 |
Henry Schein | 25,000 |
Exact Sciences | 6,600 |
Medpace Holdings | 5,900 |
Penumbra | 4,200 |
Bio-Techne | 3,050 |
Sarepta Therapeutics | 1,314 |
Exelixis | 1,310 |
CRL News
- 10 days ago - Charles River Laboratories to Present at UBS and Jefferies Conferences - Business Wire
- 14 days ago - Charles River Laboratories International, Inc. (CRL) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 15 days ago - Charles River Laboratories raises annual profit forecast on stabilizing biotech demand - Reuters
- 15 days ago - Charles River Laboratories Announces Third-Quarter 2024 Results - Business Wire
- 5 weeks ago - Charles River Launches New Retrogenix® Non-Human Protein Library - Business Wire
- 5 weeks ago - Charles River Laboratories Schedules Third-Quarter 2024 Earnings Release and Conference Call - Business Wire
- 6 weeks ago - Operadora de Fondos Banorte Adopts Charles River's Cloud-Based Platform - Business Wire
- 7 weeks ago - Charles River Provides Translational Expertise at Neuroscience 2024 - Business Wire